Bevacizumab trials for Colorectal Neoplasms
All Bevacizumab trials · All Colorectal Neoplasms trials
7
Recruiting trials
Phase breakdown
Phase 1 3Phase 3 4
Recruiting trials studying Bevacizumab for Colorectal Neoplasms
- A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
- A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
- A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
- Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Common questions
How many trials study Bevacizumab for Colorectal Neoplasms?
7 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.